Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Inventory Average (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Inventory Average for 11 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Inventory Average fell 17.82% to $9.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.4 million, a 17.82% decrease, with the full-year FY2025 number at $11.8 million, down 2.32% from a year prior.
  • Inventory Average was $9.4 million for Q4 2025 at Aytu Biopharma, down from $10.8 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $16.4 million in Q4 2021 to a low of $9.4 million in Q4 2025.
  • A 5-year average of $12.7 million and a median of $12.6 million in 2023 define the central range for Inventory Average.
  • Peak YoY movement for Inventory Average: surged 82.11% in 2021, then decreased 27.36% in 2022.
  • Aytu Biopharma's Inventory Average stood at $16.4 million in 2021, then dropped by 21.45% to $12.9 million in 2022, then grew by 0.57% to $13.0 million in 2023, then fell by 12.1% to $11.4 million in 2024, then dropped by 17.82% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Inventory Average are $9.4 million (Q4 2025), $10.8 million (Q3 2025), and $11.2 million (Q2 2025).